US Stock MarketDetailed Quotes
OTLC ONCOTELIC THERAPEUTICS INC
- 0.030000
- +0.005000+20.00%
15min DelayClose Oct 14 16:00 ET
12.19MMarket Cap-15000P/E (TTM)
0.033000High0.025000Low1.33MVolume0.026500Open0.025000Pre Close39.09KTurnover0.60%Turnover RatioLossP/E (Static)406.27MShares0.04500052wk High1.00P/B6.63MFloat Cap0.01700052wk Low--Dividend TTM221.13MShs Float0.360000Historical High--Div YieldTTM32.00%Amplitude0.010000Historical Low0.029000Avg Price1Lot Size
ONCOTELIC THERAPEUTICS INC Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 41.64%-261.77K | 7.81%-231.42K | 9.05%-1.32M | -361.85%-372.62K | -20.75%-248.85K | -120.82%-448.56K | 73.92%-251.02K | 67.24%-1.45M | 92.44%-80.68K | 77.12%-206.08K |
| Net income from continuing operations | 95.94%-278.17K | 21.59%-475.18K | -275.47%-8.21M | 85.20%-791.07K | 104.78%41.06K | -142.89%-6.85M | 88.09%-606.04K | 144.47%4.68M | -171.13%-5.34M | 53.68%-859.44K |
| Operating gains losses | -107.68%-23.63K | -112.44%-2.48K | 101.59%225.07K | 295.69%204.32K | -190.39%-306.84K | 102.17%307.7K | -89.57%19.9K | -1,014.66%-14.19M | 65.55%-104.41K | -105.42%-105.66K |
| Depreciation and amortization | ---- | ---- | --0 | --0 | ---- | ---- | ---- | -79.12%12.84K | --0 | --0 |
| Other non cash items | -24.61%64.34K | -24.13%126.27K | -69.77%675.06K | 39.70%580.23K | -136.77%-156.95K | 104.45%85.35K | -94.97%166.43K | 17.45%2.23M | -29.37%415.33K | -22.19%426.9K |
| Change In working capital | 67.47%-24.31K | -28.89%119.97K | -110.79%-86.33K | -162.60%-354.16K | 511.73%173.88K | 33.06%-74.75K | -46.82%168.7K | 162.00%799.77K | 141.58%565.76K | -87.98%28.42K |
| -Change in prepaid assets | 35.34%-37.14K | -3.65%18.73K | -1,167.80%-40.39K | 82.52%-624 | -133.26%-1.77K | -1,797.09%-57.44K | 1,121.22%19.44K | -103.83%-3.19K | -106.84%-3.57K | -95.66%5.32K |
| -Change in payables and accrued expense | 174.16%12.83K | -32.17%101.23K | -105.72%-45.94K | -162.10%-353.53K | 660.11%175.65K | 84.07%-17.3K | -53.23%149.25K | 261.43%802.96K | 140.30%569.33K | -79.73%23.11K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 41.64%-261.77K | 7.81%-231.42K | 9.05%-1.32M | -361.85%-372.62K | -20.75%-248.85K | -120.82%-448.56K | 73.92%-251.02K | 67.24%-1.45M | 92.44%-80.68K | 77.12%-206.08K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -67.05%145K | 25.00%250K | 11.09%1.25M | 302.93%275K | 456.54%335K | -12.87%440K | -59.33%200K | -75.16%1.13M | -95.62%68.25K | -88.37%60.19K |
| Net issuance payments of debt | -70.41%145K | 25.00%250K | 45.90%1.41M | 1,891.04%300K | --420K | -9.79%490K | -54.55%200K | -62.34%966.43K | -101.25%-16.75K | --0 |
| Net common stock issuance | ---- | ---- | -178.71%-125K | -200.00%-25K | -183.07%-50K | ---- | ---- | -91.92%158.82K | -89.30%25K | 24.15%60.19K |
| Net other financing activities | ---- | ---- | ---35K | --0 | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -67.05%145K | 25.00%250K | 11.09%1.25M | 302.93%275K | 456.54%335K | -12.87%440K | -59.33%200K | -75.16%1.13M | -95.62%68.25K | -88.37%60.19K |
| Net cash flow | ||||||||||
| Beginning cash position | -0.69%208.99K | -27.17%190.41K | -55.59%261.45K | 5.16%288.02K | -51.91%201.87K | 78.48%210.44K | -55.59%261.45K | 19.18%588.77K | 179.24%273.88K | -12.78%419.77K |
| Current changes in cash | -1,263.69%-116.77K | 136.43%18.58K | 78.29%-71.05K | -685.33%-97.62K | 159.05%86.15K | -102.84%-8.56K | 89.17%-51.02K | -445.45%-327.32K | -102.53%-12.43K | 61.93%-145.89K |
| End cash Position | -54.32%92.22K | -0.69%208.99K | -27.17%190.41K | -27.17%190.41K | 5.16%288.02K | -51.91%201.87K | 78.48%210.44K | -55.59%261.45K | -55.59%261.45K | 179.24%273.88K |
| Free cash flow | 41.64%-261.77K | 7.81%-231.42K | 9.05%-1.32M | -361.85%-372.62K | -20.75%-248.85K | -120.82%-448.56K | 73.92%-251.02K | 67.24%-1.45M | 92.44%-80.68K | 77.12%-206.08K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
